Hirsch, Matthew Louis
- Rainbio, Inc. (no department on record)
- Epigenos Bioscience, Inc. (no department on record)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
FY2022 NIH rank #18,118
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2015 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2022
Linked Award Amount
$631K
Full award amounts, FY2022
Award Records
2
Records listing this PI
Award-Linked Rank
#18,118
By linked amount among FY2022 PIs
Earliest Year Loaded
2015
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2022 award records by amount
NIH award records listing Hirsch, Matthew Louis as a PI. Multi-PI records show the full award amount for context.
- 1R41EY034046-01R41Contact PITolerability and Potency of Sequential and Repeated AAV Corneal Gene Therapy$367.6Kaward amount
- 1R41EY033603-01R41Contact PINovel platform for optimizing AAV transgene expression to improve efficacy of ocular gene therapies$263.4Kaward amount
Award organizations
Organizations that administered FY2022 awards listing Hirsch, Matthew Louis as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2015First NIH AwardRainbio, Inc.
- 2016$500K Cumulative Funding
- 2016$1M Cumulative Funding
- 2016Multi-Institutional ResearchAwards at 2 institutions
- 2022$2M Cumulative Funding